Patients' voices heard: comparing brain tumor treatments through their eyes

NCT ID NCT07547163

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how people with a slow-growing brain tumor (low-grade glioma) feel during different treatments. Researchers will ask 90 patients about their quality of life, symptoms, and anxiety while they receive either the drug vorasidenib, radiotherapy, or just regular check-ups. The goal is to learn which approach is easier on patients, helping doctors make better care decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
vorasidenib
What this could lead to
If successful, this could help doctors understand which treatment—vorasidenib, radiotherapy, or just monitoring—better preserves quality of life for people with low-grade gliomas.
What could go wrong
This is an observational study, not a treatment trial, so it won't prove which therapy is more effective. Results may not apply to all patients, and questionnaires may not capture every side effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione IRCCS Istituto Neurologico Carlo Besta

    RECRUITING

    Milan, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.